Native human antibody to Shr promote mice survival after intraperitoneal challenge with invasive Group A Streptococcus
Clicks: 152
ID: 111656
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
152 views
35 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #158 of 443 articles by views in The Journal of infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 443 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractBackground. A vaccine against the group A streptococcus (GAS) has been actively pursued for decades. The surface receptor Shr is vital in GAS heme upta
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (25 words).
Try re-searching for a better abstract.
| Reference Key |
nilanjanathenative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chatterjee, Nilanjana;Huang, Ya-Shu;Lyles, Kristin V;Morgan, Julie E;Kauvar, Lawrence M;Greer, Susanna F;Eichenbaum, Zehava; |
| Journal | The Journal of infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.